Lin, C.-H.; Cheng, P.-L.; Chuang, C.-Y.; Kang, Y.-T.; Lee, L.-W.; Hsiao, T.-H.; Hsu, C.-P.
The Expression of TP63 as a Biomarker of Early Recurrence in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy. Biomedicines 2024, 12, 1101.
https://doi.org/10.3390/biomedicines12051101
AMA Style
Lin C-H, Cheng P-L, Chuang C-Y, Kang Y-T, Lee L-W, Hsiao T-H, Hsu C-P.
The Expression of TP63 as a Biomarker of Early Recurrence in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy. Biomedicines. 2024; 12(5):1101.
https://doi.org/10.3390/biomedicines12051101
Chicago/Turabian Style
Lin, Chih-Hung, Po-Liang Cheng, Cheng-Yeh Chuang, Yu-Ting Kang, Li-Wen Lee, Tzu-Hung Hsiao, and Chung-Ping Hsu.
2024. "The Expression of TP63 as a Biomarker of Early Recurrence in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy" Biomedicines 12, no. 5: 1101.
https://doi.org/10.3390/biomedicines12051101
APA Style
Lin, C.-H., Cheng, P.-L., Chuang, C.-Y., Kang, Y.-T., Lee, L.-W., Hsiao, T.-H., & Hsu, C.-P.
(2024). The Expression of TP63 as a Biomarker of Early Recurrence in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy. Biomedicines, 12(5), 1101.
https://doi.org/10.3390/biomedicines12051101
